Fertin
  • Delivery systems
    • Zapliq®
    • Compressed gum
    • Extruded gum
    • Lozenge
    • Pouch powder
    • Custom delivery systems and co-development
  • Application areas
    • Nicotine
    • Cannabinoids
    • Vitamins and dietary supplements
    • Oral care
    • Energy management
    • Pain management
    • Allergy
    • Cough and cold
    • Gastrointestinal
    • Sleep and relaxation
  • Services
    • Research and development
    • Manufacturing and packaging
    • Sensory optimisation
    • Regulatory and compliance
    • Quality control and assurance
    • Intellectual property
  • News & insights
    • News
    • Insights
  • Sustainability
  • About
    • Fertin Pharma Group
    • Fertin India
    • NordicCan
    • Tab Labs
  • Careers
  • Contact
  • Search
  • Account
  • Delivery systems
    • Zapliq®
    • Compressed gum
    • Extruded gum
    • Lozenge
    • Pouch powder
    • Custom delivery systems and co-development
  • Application areas
    • Nicotine
    • Cannabinoids
    • Vitamins and dietary supplements
    • Oral care
    • Energy management
    • Pain management
    • Allergy
    • Cough and cold
    • Gastrointestinal
    • Sleep and relaxation
  • Services
    • Research and development
    • Manufacturing and packaging
    • Sensory optimisation
    • Regulatory and compliance
    • Quality control and assurance
    • Intellectual property
  • News & insights
    • News
    • Insights
  • Sustainability
  • About
    • Fertin Pharma Group
    • Fertin India
    • NordicCan
    • Tab Labs
  • Careers
  • Contact
  • Search
  • Account
Fertin
2021-03-10

NordicCan Secures Two New US Patents for the Administration of Cannabinoids through Oral Dosage Formats

NordicCan Secures Two New US Patents for the Administration of Cannabinoids through Oral Dosage Formats

2021-03-10

VEJLE, Denmark—March 5, 2021—NordicCan, a full Contract Development and Manufacturing Organisation specialized in innovative cannabinoid solutions for the B2B market, today announced that the United States Patent and Trademark Office (USPTO) has issued it two patents: U.S. Patent No. 10,925,853 and US 10,933,017 cover the use of cannabinoids within NordicCan’s oral dosage formats Zapliq Chewable Tablet and compressed chewing gum.
“We are pleased to be able to offer our B2B partners and consumers worldwide a wide range of safe, pleasant, efficient and user-friendly formats for cannabinoids. The patents are the result of many years of research and development in our laboratories and attest to our unique knowledge of combining oral delivery formats and cannabinoids,” said Jesper Neergaard, Senior Principal and Head of IPR at Fertin Pharma and NordicCan.
Patent No. 10,925,853, for “Oral Cannabinoid Tablet,” refers to delivery of cannabinoids to mucosal surfaces through Zapliq® fast liquefiable chewable tablet. Patent US 10,933,017, covering “tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers,” relates to a tableted chewing gum composition for oral administration of cannabinoids. The main objective of these technologies is to provide oral delivery dosages with cannabinoids that have a pleasurable mouthfeel through unique taste and texture.

For more information, visit www.nordiccan.com

Or contact:

Jesper Neergaard, Senior Principal, Head of IPR at Fertin Pharma JNR@fertin.com

Julie Malbaek, CEO NordicCan JULM@fertin.com

About NordicCan A/S
NordicCan, a sister company of Fertin Pharma, develops and produces innovative cannabinoid containing products based on innovative oral and intra-oral delivery systems. With a health focus, NordicCan defines its business scope within Wellness, Medicinal and Pharmaceutical approved cannabinoid containing formats. Fertin Pharma and NordicCan jointly have access to the most comprehensive portfolio of intra-oral delivery systems globally. They own a wide range of patents covering oral and intra-oral delivery technologies, which offer the patient and consumer efficient, pleasurable and convenient delivery formats.

Share
Archive
  • 2021
  • 2020
  • 2019
Deliver active and functional ingredients to your consumer in a pleasurable and effective way
Dandyvej 19, DK-7100 Vejle, Denmark
+45 7215 1300  |  fertin@fertin.com
Follow us
How can we help?
Discuss your next product with our experts today
Dandyvej 19, DK-7100 Vejle, Denmark
+45 7215 1300  |  fertin@fertin.com
Fertin Pharma 2019. All Rights Reserved.
Disclaimer | Privacy Policy | Cookie Policy | Food Safety
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.